Search Results 2461-2470 of 20314 for Receptor

  1. Movement disorders - Doctors and departments - Mayo Clinic

    ... receptor antibody encephalitis. Show more areas of focus for Andrew McKeon, M.B., B.Ch., M.D.. Kai J. Miller, M.D., Ph.D ...

  2. Evaluate The Safety, Tolerability, Pharmacokinetics And Efficacy Of BL-M05D1 In Subjects With Solid Tumors - Mayo Clinic

    2, human epidermal growth factor receptor 2 (HER2), PD-L1 and/or microsatellite instability high (MSI-H)/ mismatch repair deficiency (dMMR) positive tumors ...

  3. Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors - Mayo Clinic

    ... receptor positive (ER+/PR+, and Her2-) metastatic breast cancer, recurrent GBM, GASTRIC/GASTROESOPHAGEAL JUNCTION CANCER, advanced pancreatic adenocarcinoma ...

  4. Mayo Clinic School of Health Sciences 2026 Radiography Program – Jacksonville, Florida

    37 Holding Patients or Image Receptors ... This course presents Digital Radiography, including the design and function of digital image receptors, histogram ...

  5. Neurology - Clinical trials - Mayo Clinic

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  6. Neurology - Clinical trials

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  7. Rolapitant (intravenous route) - Mayo Clinic

    This medicine is a substance P/neurokinin 1 (NK1) receptor antagonist that works by blocking the signals to the brain that cause nausea and vomiting. This ...

  8. Radiation Oncology - Clinical trials

    Memantine hydrochloride may enhance cognitive function by binding to and inhibiting channels of receptors located in the central nervous system. Radiation ...

  9. Publications - Terrence L. Trentman, M.D. - Mayo Clinic

    Mediation of serotonin-induced analgesia by the 5HT2 receptor in the phenobarbital anesthetized mouse model. Brain Res Bull. 1988 Dec; 21(6):887-892. View ...

  10. A Study To Evaluate Atumelnant In Adults With Congenital Adrenal Hyperplasia - Mayo Clinic

    Use of a corticotropin-releasing factor receptor antagonist within 14 days of Screening. Note: Other protocol defined Inclusion/Exclusion Criteria may apply ...